Probiotic-Based Materials as Living Therapeutics.
- 2025-09-25
- Review
- Advanced materials (Deerfield Beach, Fla.) 38(1)
- Laura Sabio
- Graham J Day
- Manuel Salmeron-Sanchez
- PubMed: 40999775
- DOI: 10.1002/adma.202508500
- Low evidence
consumption of Bifidobacterium lactis HA-194 was associated with a reduction in gastrointestinal symptoms including bloating, abdominal pain, and discomfort
- Effect
- Beneficial
- Effect size
- Small